BG107476A - Метод за получаване на свръхчист фармацевтичен полупродукт 4-(циклопропилкарбонил)-алфа,алфа-диметилфенилоцетна киселина - Google Patents

Метод за получаване на свръхчист фармацевтичен полупродукт 4-(циклопропилкарбонил)-алфа,алфа-диметилфенилоцетна киселина Download PDF

Info

Publication number
BG107476A
BG107476A BG107476A BG10747603A BG107476A BG 107476 A BG107476 A BG 107476A BG 107476 A BG107476 A BG 107476A BG 10747603 A BG10747603 A BG 10747603A BG 107476 A BG107476 A BG 107476A
Authority
BG
Bulgaria
Prior art keywords
formula
alpha
cyclopropylcarbonyl
mixture
preparation
Prior art date
Application number
BG107476A
Other languages
Bulgarian (bg)
English (en)
Inventor
Ramesh Dandala
Umashankar Das
Divvela V. Naga Srinivasa Rao
Meenakshi S. Sivakumaran
Original Assignee
Aurobindo Pharma Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurobindo Pharma Limited filed Critical Aurobindo Pharma Limited
Publication of BG107476A publication Critical patent/BG107476A/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/42—Separation; Purification; Stabilisation; Use of additives
    • C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pulmonology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG107476A 2001-06-25 2003-01-17 Метод за получаване на свръхчист фармацевтичен полупродукт 4-(циклопропилкарбонил)-алфа,алфа-диметилфенилоцетна киселина BG107476A (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN511CH2001 2001-06-25
PCT/IN2002/000135 WO2003000658A1 (en) 2001-06-25 2002-06-19 PROCESS FOR THE PREPARATION OF A HIGHLY PURE PHARMACEUTICAL INTERMEDIATE, 4-(CYCLOPROPYLCARBONYL)-α,α-DIMETHYLPHENYLACETIC ACID

Publications (1)

Publication Number Publication Date
BG107476A true BG107476A (bg) 2004-01-30

Family

ID=29765111

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107476A BG107476A (bg) 2001-06-25 2003-01-17 Метод за получаване на свръхчист фармацевтичен полупродукт 4-(циклопропилкарбонил)-алфа,алфа-диметилфенилоцетна киселина

Country Status (7)

Country Link
US (1) US6903232B2 (cg-RX-API-DMAC10.html)
EP (1) EP1401815A1 (cg-RX-API-DMAC10.html)
JP (1) JP2004521942A (cg-RX-API-DMAC10.html)
BG (1) BG107476A (cg-RX-API-DMAC10.html)
SI (1) SI21232A (cg-RX-API-DMAC10.html)
SK (1) SK712003A3 (cg-RX-API-DMAC10.html)
WO (1) WO2003000658A1 (cg-RX-API-DMAC10.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8168234B2 (en) * 2001-06-20 2012-05-01 Metaproteomics, Llc Compositions that treat or inhibit pathological conditions associated with inflammatory response
WO2003104197A1 (en) * 2002-06-10 2003-12-18 Teva Pharmaceutical Industries Ltd. Polymorphic form xvi of fexofenadine hydrochloride
DE102004031849A1 (de) 2004-06-30 2006-01-26 Sanofi-Aventis Deutschland Gmbh Verfahren zur Carbonylierung von Phenylalkylderivaten mit Kohlenmonoxid
WO2007007347A1 (en) * 2005-07-07 2007-01-18 Wockhardt Limited Industrial process of fexofenadine hydrochloride with controlled side products
CN102659667B (zh) * 2012-04-20 2013-08-14 浙江启明药业有限公司 一种非索非那定关键中间体的合成方法
ITMI20131652A1 (it) 2013-10-07 2015-04-08 Dipharma Francis Srl Procedimento per la purificazione di derivati dell'acido 2-fenil-2-metil-propanoico
RS59874B1 (sr) 2015-10-22 2020-03-31 Sanofi Aventis Deutschland Proces za pripremu feksofenadina i njegovih intermedijara

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020007068A1 (en) * 1999-07-16 2002-01-17 D'ambra Thomas E. Piperidine derivatives and process for their production
DK1026147T3 (da) * 1993-06-24 2004-03-22 Albany Molecular Res Inc Forbindelser, der er anvendelige som mellemprodukter i fremstillingen af piperidinderivater

Also Published As

Publication number Publication date
SI21232A (sl) 2003-12-31
EP1401815A1 (en) 2004-03-31
US6903232B2 (en) 2005-06-07
SK712003A3 (en) 2003-12-02
WO2003000658A1 (en) 2003-01-03
US20040077900A1 (en) 2004-04-22
JP2004521942A (ja) 2004-07-22

Similar Documents

Publication Publication Date Title
AU612621B2 (en) Benzoylpiperidines and benzoylpiperidine oxides and oximes and their preparation
JP2004515536A (ja) 2−ブチル−3−(4−[3−(ジブチルアミノ)プロポキシ]ベンゾイル)−5−ニトロベンゾフラン塩酸塩およびその製造
RU2160731C2 (ru) Промежуточные продукты для получения 1-бензил-4-((5,6-диметокси-1-инданон)-2-ил)-метилпиперидина, способы их получения и способ получения 1-бензил-4-((5,6-диметокси-1-инданон)-2-ил)-метилпиперидина с их применением
JP2008094848A (ja) 新規な型の4−[4−[4−(ヒドロキシジフェニルメチル)−1−ピペリジニル]−1−ヒドロキシブチル]−α,α−ジメチルベンゼン酢酸及びその塩酸塩
JP4344230B2 (ja) ピペリジン誘導体フェキソフェナジンの製造方法
EP2044021B1 (en) Process for preparing remifentanil, intermediates thereof, use of said intermediates and processes for their preparation
AU2002320847A1 (en) Process for the production of the piperidine derivative fexofenadine
US6903232B2 (en) Process for the preparation of a highly pure pharmaceutical intermediate, 4-(cyclopropylcarbonyl)-α, α-dimethylphenylacetic acid
AU2001278094A1 (en) Novel crystalline forms of 4-[4-[4-(hydroxydiphenylmethyl)-1-piperindinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzene acetic acid and its hydrochloride
JP2004521942A5 (cg-RX-API-DMAC10.html)
RU2248974C2 (ru) Способ получения {2-[4-(альфа-фенил-п-хлорбензил)пиперазин-1-ил]-этокси}-уксусной кислоты и новые промежуточные соединения
IE60280B1 (en) "Preparation process for derivatives of octahydroindole and preparation intermediates"
EP1673365B1 (en) Process for the preparation of z-flupentixol
JPH0521105B2 (cg-RX-API-DMAC10.html)
US5112978A (en) Process for preparing alpha (alkyl phenyl)-4(hydroxy-diphenylmethyl)-1-piperidinyl butanol
SK20192000A3 (sk) Soli n-terc-butylhydroxylamínu
JP3647455B2 (ja) 3−イソオキサゾールカルボン酸の製造方法
HU194857B (en) Process for production of 4-amin-6-fluor-cromane-4-carbonic acid and its 2/r/ methilesther
CZ20041196A3 (cs) Způsob přípravy terfenadinu a jeho derivátů
JPH0160466B2 (cg-RX-API-DMAC10.html)
EP2289867A2 (en) A process for producing 4-(4-halo-1-oxybutyl)-alpha,alpha-dimethylbenzene acetic acid or alkyl esters thereof
JPH08505404A (ja) 中間体としてのキノロン二硫化物